EM915 | 1313489-72-3

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: EM915
• 英文别名: [(2S,3R,4S,6R)-2-[[(1S,2S,3R,6R,7S,8S,9R,10R,12R)-3-[(2R,3R)-2,3-dihydroxypentan-2-yl]-7-hydroxy-2,6,8,10,12-pentamethyl-5-oxo-4,13-dioxabicyclo[8.2.1]tridecan-9-yl]oxy]-4-(dimethylamino)-6-methyloxan-3-yl] acetate
• CAS: 1313489-72-3
• 化学式: C₃₁H₅₅NO₁₀
• 分子量: 601.778
• InChiKey: OVUATHRELNLAFR-SDYMZTNJSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  42
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.94
• 拓扑面积：
  144
• 氢给体数：
  3
• 氢受体数：
  11

反应信息

• 作为反应物：
  描述：

  EM915 在 吡啶 、 甲醇 、 戴斯-马丁氧化剂 作用下， 以 二氯甲烷 为溶剂， 反应 32.5h， 生成 EM918
  参考文献：
  名称：

  Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

  摘要：

  Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9- dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R, 9S)-4 '',13-O-diacetyl- 8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.04.004
• 作为产物：
  描述：

  (8R,9S)-8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin 在 盐酸 作用下， 以 水 、 丙酮 为溶剂， 反应 5.5h， 生成 EM915
  参考文献：
  名称：

  Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents

  摘要：

  Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9- dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R, 9S)-4 '',13-O-diacetyl- 8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.04.004

文献信息

• Novel 12-membered non-antibiotic macrolides from erythromycin A; EM900 series as novel leads for anti-inflammatory and/or immunomodulatory agents
  作者：Akihiro Sugawara、Akito Sueki、Tomoyasu Hirose、Kenichiro Nagai、Hiroaki Gouda、Shuichi Hirono、Hideaki Shima、Kiyoko S. Akagawa、Satoshi Ōmura、Toshiaki Sunazuka

  DOI：10.1016/j.bmcl.2011.04.004

  日期：2011.6

  Herein, we report the design and synthesis of the novel 12-membered non-antibiotic macrolide (8R,9S)-8,9- dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM900), which was found to be a potent anti-inflammatory and/or immunomodulatory agent, capable of promoting monocyte to macrophage differentiation. This molecule shows improved acid stability, does not exhibit any anti-bacterial activity and has relatively low cytotoxicity against THP-1 cells. In addition, one of its analogues, (8R, 9S)-4 '',13-O-diacetyl- 8,9-dihydro-6,9-epoxy-8,9-anhydropseudoerythromycin A (EM911), was found to be twice as effective as EM900. (C) 2011 Elsevier Ltd. All rights reserved.